Clinical TrialsSearch results
Number of results: 386
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Zoledronate dose comparison study for patients with a proximal femur fracture
- Proximal femur fracture
- Osaki Makoto
- 2024-07-22
Recruiting
- Nab-TET
- Thymic epithelial tumors (thymoma, thymic carcinoma) with a confirmed pathological diagnosis
- Takemoto Shinnosuke
- 2024-06-06
Recruiting
- A Prospective Interventional Study for CPA
- Chronic Pulmonary Aspergillosis
- Izumikawa Koichi
- 2024-03-04
Other
- Long-term Safety and Efficacy of Filgotinib in Patients with Idiopathic Multicentric Castleman's Disease (iMCD)
- idiopathic multicentric Castleman's disease
- Kawakami Atsushi
- 2024-03-04
Completed
- Investigator-Initiated Study of Filgotinib in Patients with Idiopathic Multicentric Castleman Disease (iMCD)
- idiopathic multicentric Castleman's disease
- Kawakami Atsushi
- 2024-01-22
Recruiting
- Study to Evaluate the Efficacy and Safety of K-808 (pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment
- Primary Biliary Cholangitis
- Tanigawa Ryohei
- 2024-01-18
Recruiting
- A new canalith repositioning procedure for posterior canal short-arm type of benign paroxysmal positional vertigo
- Some subjects may experience neck pain or stiff shoulders due to parietal position method.
- Shigeno Kohichiro
- 2024-01-10
Completed
- Comparison of povidone-iodine and brushing on reducing the number of bacteria on cuffs intubated patients
- Oral tumor
- Soutome Sakiko
- 2023-12-25
Recruiting
- Phase 3 Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) (SUCCESSOR-1)
- Relapsed or Refractory Multiple Myeloma (RRMM)
- Nishio Mitsufumi
- 2023-12-04
Recruiting
- Nagasaki ROAD study
- Acute respiratory infection due to respiratory syncytial virus
- Takazono Takahiro
- 2023-11-05